Tirzepatide

Tirzepatide is a synthetic peptide that acts as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It is widely studied in laboratory research involving metabolic signalling, receptor activity, energy regulation and related biological pathways.

Product Features

• High-quality research material
• Suitable for controlled laboratory and analytical studies
• Supplied in a securely sealed and clearly labelled vial
• Supports research involving GIP and GLP-1 receptor pathways
• Intended for handling by qualified research professionals

Storage

Keep the vial securely sealed and store it according to the conditions stated on the product label, certificate of analysis or accompanying documentation. Protect it from excessive heat, moisture and direct sunlight.

Important Notice

FDA-approved prescription products containing tirzepatide include specific Mounjaro and Zepbound formulations. This does not mean that every product labelled as tirzepatide is FDA-approved or equivalent to those prescription medicines.

The FDA has raised concerns about unapproved GLP-1 products because their quality, safety and effectiveness have not been reviewed through the FDA approval process. Unapproved products must not be marketed as generic, identical or clinically equivalent alternatives to approved medicines.

For laboratory research purposes only. Not for human or veterinary use. Not intended to diagnose, treat, cure or prevent any disease.